Gene therapy for all aspects of vein-graft disease

Journal of Cardiac Surgery

Volumn 17, Issue 6, 2002, Pages 549-555

  White, Stephen J ^a   Phil, D ^a   Newby, Andrew C ^a,b  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b BRISTOL ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1 ANTIBODY; INTERLEUKIN 10; MONOCLONAL ANTIBODY; NITRIC OXIDE SYNTHASE; OLIGONUCLEOTIDE; PROSTACYCLIN SYNTHASE; PROTEIN P53; TISSUE FACTOR PATHWAY INHIBITOR; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TISSUE PLASMINOGEN ACTIVATOR; TRANSCRIPTION FACTOR E2F; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1 ANTIBODY;

ARTERY INTIMA PROLIFERATION; ATHEROSCLEROSIS; CONFERENCE PAPER; GENE TARGETING; GENE THERAPY; GRAFT OCCLUSION; HUMAN; MOUSE; NONHUMAN; SAPHENOUS VEIN GRAFT; SMOOTH MUSCLE FIBER; SWINE; THROMBOGENESIS; THROMBOSIS; VEIN GRAFT;

ANIMALS; ARTERIOSCLEROSIS; CORONARY VESSELS; GENE THERAPY; GRAFT OCCLUSION, VASCULAR; HUMANS; SAPHENOUS VEIN; TUNICA INTIMA; VENOUS THROMBOSIS;

EID: 0036869864     PISSN: 08860440     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1540-8191.2002.01013.x     Document Type: Conference Paper

References (36)

1. Grondin CM, Campeau L, Lesperance J, et al. Comparison of late changes in internal mammary artery and saphenous veins in two consecutive series of patients 10 years after operation. Circulation 1984;70(suppl. 1):1208-1212.
2. Mann MJ, Whittemore AD, Donaldson MC, et al. Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: The PREVENT single-centre, randomised, controlled trial. Lancet 1999;354:1493-1498.
3. Mann MJ, Gibbons GH, Kernoff RS, et al. Genetic-engineering of vein grafts resistant to atherosclerosis. Proceedings of the National Academy of Sciences of the United States of America. 1995;92:4502-4506.
4. West NE J, Qian HS, Guzik TJ, et al. Nitric oxide synthase (nNOS) gene transfer modifies venous bypass graft remodeling: Effects on vascular smooth muscle cell differentiation and superoxide production. Circulation 2001;104:1526-1532.
5. Ehsan A, Mann MJ, Dell'Acqua G, et al. Long-term stabilization of vein graft wall architecture and prolonged resistance to experimental atherosclerosis after E2F decoy oligonucleotide gene therapy. J Thoracic Cardiovascular Surg 2001;121:714-722.
6. Zhou YP, Dietrich H, Hu YH, et al. Mouse model of venous bypass graft arteriosclerosis. Am J Pathol 1998;153:1301-1310.
7. Dietrich H, Hu YH, Zhou YP, et al. Rapid development of vein graft atheroma in ApoE-deficient mice. Am J Pathol 2000;157:659-669.
8. Hu YH, Baker AH, Zhou YP, et al. Local gene transfer of tissue inhibitor of metalloproteinase-2 influences vein graft remodeling in a mouse model. Arterioscler Thromb Vasc Biol 2001;21:1275-1280.
9. Matsumoto T, Komori K, Yonemitsu Y, et al. Hemagglutinating virus of Japan-liposome-mediated gene transfer of endothelial cell nitric oxide synthase inhibits intimal hyperplasia of canine vein grafts under conditions of poor runoff. J Vascular Surg 1998;27:135-144.
10. Angelini GD, Bryan AJ, Williams HMJ, et al. Distention promotes platelet and leukocyte adhesion and reduces short-term patency in pig arteriovenous bypass grafts. J Thorac Cardiovasc Surg 1990;99:433-439.
11. Mehta D, George SJ, Jeremy JY, et al. External stenting reduces long term medial and neointimal thickening and platelet derived growth factor expression in a pig model of arteriovenous bypass grafting. Nature Med 1998;4:235-239
12. Soyombo AA, Angelini GD, Bryan AJ, et al. Intimal proliferation in an organ-culture of human saphenous vein. Am J Pathol 1990;137:1401-1410.
13. George SJ, Johnson JL, Angelini GD, et al. Short-term exposure to thapsigargin inhibits neointima formation in human saphenous vein. Arterioscler Thromb Vasc Biol 1997;17:2500-2506.
14. Anonymous. Collaborative overview of randomised trials of antiplatelet therapy: II. Maintenance of vascular graft or arterial patency by antiplatelet therapy. Br Med J 1994;308:159-168.
15. Baker AH, Mehta D, George SJ, et al. Prevention of vein graft failure: Potential applications for gene therapy. Cardiovasc Res 1997;35:442-450.
16. Angelini GD, Breckenridge IM, Psaila JV, et al. Preparation of human saphenous vein for coronary artery bypass grafting impairs its capacity to produce prostacyclin. Cardiovasc Res 1987;21:28-33.
17. Angelini GD, Christie M, Bryan AJ, et al. Preparation of human saphenous vein for coronary artery bypass grafting impairs its capacity to release endothelium derived relaxant factor. [abstract] Br Heart J 1988;59:613.
18. Shyue SK, Tsai MJ, Liou JY, et al. Selective augmentation of prostacyclin production by combined prostacyclin synthase and cyclooxygenase-1 gene transfer. Circulation 2001;103:2090-2095.
19. Zoldhelyi P, Chen ZQ, Shelat HS, et al. Local gene transfer of tissue factor pathway inhibitor regulates intimal hyperplasia in atherosclerotic arteries. Proceedings of the National Academy of Sciences of the United States of America. 2001;98:4078-4083.
20. Izzard TD, Taylor C, Birkett SD, et al. Mechanisms underlying maintenance of smooth muscle cell quiescence in rat aorta: Role of the cyclin dependent kinases and their inhibitors. Cardiovasc Res 2002;53:242-252.
21. George SJ, Baker AH, Angelini GD, et al. Gene transfer of tissue inhibitor of metalloproteinase-2 inhibits metalloproteinase activity and neointima formation in human saphenous veins. Gene Ther 1998;5:1552-1560.
22. George SJ, Johnson JL, Angelini GD, et al. Adenovirus-mediated gene transfer of the human TIMP-1 gene inhibits smooth muscle cell migration and neointimal formation in human saphenous vein. Human Gene Ther 1998;9:867-877.
23. George SJ, Lloyd CT, Angelini GD, et al. Inhibition of late vein graft neointima formation in human and porcine models by adenovirus-mediated overexpression of tissue inhibitor of metalloproteinase-3. Circulation 2000;101:296-304.
24. George SJ, Angelini GD, Capogrossi MC, et al. Wild-type p53 gene transfer inhibits neointima formation in human saphenous vein by modulation of smooth muscle migration and induction of apoptosis. Gene Ther 2001;8:668-676.
25. von der Leyen HE, Braun-Dullaeus R, Mann MJ, et al. A pressure-mediated nonviral method for efficient arterial gene and oligonucleotide transfer. Human Gene Ther 1999;10:2355-2364.
26. Mann MJ, Gibbons GH, Hutchinson H, et al. Pressure-mediated oligonucleotide transfection of rat and human cardiovascular tissues. Proceedings of the National Academy of Sciences of the United States of America. 1999;96:6411-6416.
27. Kibbe MR, Tzeng E, Gleixner SL, et al. Adenovirus-mediated gene transfer of human inducible nitric oxide synthase in porcine vein grafts inhibits intimal hyperplasia. J Vascular Surg 2001;34:156-165.
28. Zou YP, Hu YH, Mayr M, et al. Reduced neointima hyperplasia of vein bypass grafts in intercellular adhesion molecule-1-deficient mice. Circulation Res 2000;86:434-440.
29. Qian HS, Neplioueva V, Shetty CA, et al. Nitric oxide synthase gene therapy rapidly reduces adhesion molecule expression and inflammatory cell infiltration in carotid arteries of cholesterol-fed rabbits. Circulation 1999;99:2979-2982.
30. Shears LL, Kawaharada N, Tzeng E, et al. Inducible nitric oxide synthase suppresses the development of allograft arteriosclerosis. J Clin invest 1997;100:2035-2042.
31. Chester AH, Morrison KJM, Yacoub MH. Expression of vascular adhesion molecules in saphenous vein coronary bypass grafts. Ann Thoracic Surg 1998;65:1685-1689.
32. Crook MF, Newby AC, Southgate KM. Expression of intercellular adhesion molecules in human saphenous veins: Effects of inflammatory cytokines and neointima formation in culture. Atherosclerosis 2000;150:33-41.
33. Crook MF, Southgate KM, Newby AC. Both ICAM-1- and VCAM-1-integrin interactions are important in mediating monocyte adhesion to human saphenous vein. J Vasc Res 2002; in press.
34. Chen S, Wilson J, Muller D. Adenovirus-mediated gene transfer of soluble vascular cell adhesion molecule to porcine interposition vein grafts. Circulation 1994;89:1922-1928.
35. von der Thusen JH, Kuiper J, Fekkes ML, et al. Attenuation of atherogenesis by systemic and local adenovirus-mediated gene transfer of interleukin-10 in LDLr -/- mice. FASEB J 2001;15:2730-2732.
36. Feldman LJ, Aguirre L, Ziol M, et al. Interleukin-10 inhibits intimal hyperplasia after angioplasty or stent implantation in hypercholesterolemic rabbits. Circulation 2000;101:908-916.